American Herbal Products Association (AHPA) > About Us > Committees > Chinese Herbal Products Committee

Chinese Herbal Products Committee

Chair: Bill Egloff (Crane Herb Company)
Staff Contact: Michael McGuffin

Committee Purpose: To promote responsible commerce of those herbs and herbal products that are included in and/or based on traditional use of Chinese herbs.

AHPA Members, if you would like to join this committee, please email the staff contact.

Committee Resources

Committee Meeting Minutes

March 12, 2021 Meeting Minutes

Meeting of the Chinese Herbal Products Committee

AHPA Members log in to download the meeting minutes.

November 13, 2020 Meeting Minutes

Meeting of the Chinese Herbal Products Committee

AHPA Members log in to download the meeting minutes.

March 20, 2020 Meeting Minutes

Meeting of the Chinese Herbal Products Committee

AHPA Members log in to download the meeting minutes.

October 31, 2019 Meeting Minutes

Meeting of the Chinese Herbal Products Committee

AHPA Members log in to download the meeting minutes.

August 30, 2019 Meeting Minutes

Meeting of the Chinese Herbal Products Committee

AHPA Members log in to download the meeting minutes.
RSS

Committee-Related News

“Phase One” agreement with China provides some relief to supplement importers

January 2020: Reduced tariffs will affect imports filed after February 14

A partial trade agreement signed by the United States and China on January 15, 2020, will reduce U.S.-imposed tariffs on some imported Chinese goods used by U.S. dietary supplement and food companies, but it will leave tariffs on other commodities in place, at least for the short term.

Guidance on allergens in Traditional Chinese Medicine (TCM)

Free guidance for AHPA members

AHPA published guidance, “Compliance with the Food Allergen Labeling and Consumer Protection Act for Marketers of Chinese Herbal Products,” to provide members with a summary of Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA) and identify ingredients and preparations found in traditional Chinese herbal ingredients and formulas that may require labeling as major food allergens.

AHPA urges USTR to exempt herbal product ingredients from proposed China tariff increases

June 2019: Herbal ingredients should be excluded from tariff increases because supplements and food play important roles in the health of U.S. consumers

The American Herbal Products Association (AHPA) urged the U.S. Trade Representative (USTR) to remove herbal product ingredients from a list of Chinese goods that would be subject to a 25 percent ad valorem duty under a recent USTR proposal to increase tariffs on an estimated $300 billion worth of Chinese imports.

U.S. increases and proposes expansion of tariffs on Chinese imports

May 2019: China announces additional tariffs on any plant mainly used as a spice

The U.S. Trade Representative (USTR) announced on May 9 that it increased tariffs on approximately $200 billion worth of Chinese imports initially identified in September 2018 from 10 percent to 25 percent.

Guidance on California Proposition 65 for herbal products

Updated August 2018, this guidance covers heavy metals, naturally occurring substances and two processed botanicals

Updated Proposition 65 guidance informs the herbal products industry about legal liabilities related to naturally occurring substances in some natural products sold in the state of California

New U.S. tariffs proposed on Chinese imports of many herb and supplement ingredients

Proposal would increase tariffs on flax, hemp seed, ginseng, mushrooms, fish oils, minerals, and more

The U.S. Trade Representative (USTR) is proposing an additional 10 percent ad valorem duty on numerous Chinese imports with an annual trade value of approximately $200 billion. The list of products of China identified by USTR as subject to this new proposed tariff includes many herbal and plant-derived substances as well as a number of other ingredients found in dietary supplements.

White paper: Good Herbal Compounding and Dispensing Practices

Best practices for compounding and dispensing herbal formulations

The American Herbal Products Association (AHPA) has issued a white paper to guide qualified practitioners who compound herbal formulations for clients based on one-on-one consultations.

Chinese herbal therapy debuts at Cleveland Clinic, University Hospitals

Changes made to state laws have opened the door for certified herbal therapists to prescribe custom Chinese herbal therapy blends and traditional formulas to patients within a clinical practice.
RSS

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.